ketamine

Advisory Panel Recommends FDA Approval of Esketamine, with New Mechanism to Treat Resistant Depression

On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid... Read More

Seeking the Optimal Dose for Ketamine’s Short-Term Rapid Antidepressant Effects

Although many studies in recent years have provided evidence that ketamine, an anesthetic drug, can provide rapid relief to people... Read More

Researchers Discover That Fast-Acting Antidepressant Ketamine Engages the Body’s Opioid System

Alan F. Schatzberg, M.D. Stanford University School of Medicine Scientific Council Member (Joined 2005) 2005 Falcone Prizewinner for Outstanding Achievement... Read More

A Test of Ketamine in Adolescents With Resistant Depression

A small study of intravenous ketamine treatment for adolescents with treatment-resistant depression indicates that the drug may be an effective... Read More

Esketamine Reduced Suicidal Thoughts Within Hours of Treatment in Patients with Severe Depression